Interrelationship between MYC gene numerical aberrations and protein expression in individuals from northern Brazil with early gastric adenocarcinoma

2008 ◽  
Vol 181 (1) ◽  
pp. 31-35 ◽  
Author(s):  
Láuren Cláudia Costa Raiol ◽  
Evely Cristina Figueira Silva ◽  
Diana Mendes da Fonseca ◽  
Mariana Ferreira Leal ◽  
Adriana Costa Guimarães ◽  
...  
2007 ◽  
Vol 179 (1) ◽  
pp. 45-51 ◽  
Author(s):  
Adriana Costa Guimarães ◽  
Eleonidas Moura Lima ◽  
André Salim Khayat ◽  
Mário Henrique Girão Faria ◽  
Silvia Helena Barem Rabenhorst ◽  
...  

2006 ◽  
Vol 5 (9) ◽  
pp. 1638-1646 ◽  
Author(s):  
Peter Ellmark ◽  
Johan Ingvarsson ◽  
Anders Carlsson ◽  
B. Samuel Lundin ◽  
Christer Wingren ◽  
...  

2021 ◽  
Vol Volume 13 ◽  
pp. 4129-4134
Author(s):  
Ming Tang ◽  
Peng-Jie Liu ◽  
Bing Yue ◽  
Xuan-Tao Yang ◽  
Guang-Yong Chen

2006 ◽  
Vol 19 (1) ◽  
pp. 205873920601900 ◽  
Author(s):  
C. Greco ◽  
I. D'Agnano ◽  
G. Vitelli ◽  
R. Vona ◽  
M. Marino ◽  
...  

Oncogenes are important regulators of cancer growth and progression and their action may be modulated by proteins of the growth factor family, such as angiogenic cytokines, known to be strongly involved in neoplastic evolution. Reciprocal interactions between oncogenes and angiogenic modulators may represent, in haematological neoplasms, including multiple myeloma (MM), a possible mechanism of drug resistance. The aim of this work is to investigate in vitro and in vivo whether or not c-myc deregulation is involved in the melphalan resistance elicited by myeloma patients and consequently to clarify the role of the angiogenic factor PDGF-BB in modulating c-myc protein expression. Fifty-one MM patients on chemotherapy with melphalan were analyzed for structural alterations of the c-myc gene, c-Myc protein expression, as well as for serum PDGF-BB release. For the in vitro study, two M14-derived established cell clones, differing for the c-Myc protein expression (c-Myc low -expressing or constitutively expressing clones) were used. Our results show that PDGF-BB is able to up-regulate Myc expression and reduce melphalan sensitivity of tumor cell clones, constitutively expressing c-myc gene product. In addition, down-regulation of c-Myc protein induces the expression of PDGF-β receptor molecules and reduces PDGF-BB release. In agreement with these results, in vivo data show that melphalan-resistant MM patients present overexpressed c-Myc protein and higher serum PDGF-β receptor levels compared to minor responding patients.


2005 ◽  
Vol 5 (4) ◽  
pp. 161-168 ◽  
Author(s):  
A. S. Khayat ◽  
L. Lobo Gatti ◽  
E. Moura Lima ◽  
P. P. de Assumpção ◽  
F. J. Nascimento Motta ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document